The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second interim analysis of CABONEN: An international, multicenter phase II trial investigating cabozantinib in patients with advanced, low proliferative NEN G3.
 
Alexander Koenig
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Roche; SERVIER
 
Johanna Reinecke
No Relationships to Disclose
 
Jessica Halfen
No Relationships to Disclose
 
Kristina Lang
No Relationships to Disclose
 
Ute Koenig
No Relationships to Disclose
 
Ralf Tostmann
No Relationships to Disclose
 
Nicole Kirchhof
No Relationships to Disclose
 
Thomas Asendorf
No Relationships to Disclose
 
Dieter Hörsch
No Relationships to Disclose
 
Anke Kröcher
Honoraria - Ipsen; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Novartis; SERVIER
 
Michael Quante
No Relationships to Disclose
 
Volker Ellenrieder
No Relationships to Disclose
 
Nadine Schulte
No Relationships to Disclose
 
Thomas Wirth
No Relationships to Disclose
 
Alexander Weich
No Relationships to Disclose
 
Leonidas Apostolidis
Honoraria - BMS; Ipsen; Novartis
Consulting or Advisory Role - Novartis
Research Funding - Camurus (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen; Novartis
 
Anja Rinke
No Relationships to Disclose
 
Marianne Pavel
Honoraria - Advanced Accelerator Applications; Boehringer Ingelheim; IPSEN; Lilly; MSD; Novartis; Recordati; Riemser; Sanofi; Serb
Consulting or Advisory Role - Advanced Accelerator Applications; Crinetics Pharmaceuticals (Inst); IPSEN; Isotopen Technologien; Novartis
Travel, Accommodations, Expenses - Recordati
 
Sebastian Krug
No Relationships to Disclose
 
Thomas Seufferlein
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Falk Foundation; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Cantargia AB; Mirati Therapeutics; Olympus Medical Systems; Pierre Fabre; Scandion Oncology; SERVIER
Research Funding - Lilly/ImClone (Inst)
Travel, Accommodations, Expenses - Takeda